Literature DB >> 15195932

Novel approaches to ocular drug delivery.

Jennifer L Davis1, Brian C Gilger, Michael R Robinson.   

Abstract

Recent advances in surgical techniques, therapeutic approaches and materials sciences have produced revolutionary new therapies for ocular diseases. The development of prodrug formulations and permeability enhancers, sustained-release drug delivery devices, novel injectable medications and new and improved vectors, both viral and non-viral, for delivery of genes to all segments of the eye has greatly increased the chances of success in treating eye diseases. This review will discuss the most recent advances in drug delivery systems for the treatment of ocular diseases.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15195932

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN： 1464-8431


  16 in total

Review 1.  Biodegradable implants for sustained drug release in the eye.

Authors:  Susan S Lee; Patrick Hughes; Aron D Ross; Michael R Robinson
Journal:  Pharm Res       Date:  2010-06-10       Impact factor: 4.200

2.  Ultrasound-enhanced delivery of antibiotics and anti-inflammatory drugs into the eye.

Authors:  Marjan Nabili; Hetal Patel; Sankaranarayana P Mahesh; Ji Liu; Craig Geist; Vesna Zderic
Journal:  Ultrasound Med Biol       Date:  2013-02-13       Impact factor: 2.998

3.  Self-assembled phenylalanine-α,β-dehydrophenylalanine nanotubes for sustained intravitreal delivery of a multi-targeted tyrosine kinase inhibitor.

Authors:  Jiban J Panda; Sarath Yandrapu; Rajendra S Kadam; Virander S Chauhan; Uday B Kompella
Journal:  J Control Release       Date:  2013-09-25       Impact factor: 9.776

Review 4.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Authors:  Samir Mitragotri; Paul A Burke; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-08-08       Impact factor: 84.694

Review 5.  Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications.

Authors:  Blake A Booth; Lori Vidal Denham; Saadallah Bouhanik; Jean T Jacob; James M Hill
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 6.  Fouling in ocular devices: implications for drug delivery, bioactive surface immobilization, and biomaterial design.

Authors:  Onyinye J Uwaezuoke; Pradeep Kumar; Viness Pillay; Yahya E Choonara
Journal:  Drug Deliv Transl Res       Date:  2021-01-16       Impact factor: 4.617

7.  Ophthalmic delivery of hydrophilic drugs through drug-loaded oleogels.

Authors:  Russell Macoon; Anuj Chauhan
Journal:  Eur J Pharm Sci       Date:  2020-11-01       Impact factor: 4.384

8.  Ocular inserts - Advancement in therapy of eye diseases.

Authors:  Anita Kumari; Pramod K Sharma; Vipin K Garg; Garima Garg
Journal:  J Adv Pharm Technol Res       Date:  2010-07

9.  Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.

Authors:  Che-Yi Chang; Ming-Chen Wang; Takuya Miyagawa; Zhi-Yu Chen; Feng-Huei Lin; Ko-Hua Chen; Guei-Sheung Liu; Ching-Li Tseng
Journal:  Int J Nanomedicine       Date:  2016-12-30

10.  Hyaluronic Acid-Pluronic®F127-Laden Soft Contact Lenses for Corneal Epithelial Healing: In Vitro and In Vivo Studies.

Authors:  Ning Wei; Xianghui Xu; Chao Huang; Lijun Cao
Journal:  AAPS PharmSciTech       Date:  2020-06-02       Impact factor: 4.026
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.